StockNews.AI
SRTS
StockNews.AI
12 hrs

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS

1. Pomerantz LLP is investigating potential securities fraud at Sensus Healthcare. 2. Sensus reported a -$0.06 EPS, missing estimates significantly. 3. Revenue declined by 20.7% year-over-year, impacting stock value. 4. Stock fell 35.32% to $3.46 per share post-earnings report. 5. Investors are encouraged to join the class action lawsuit.

4m saved
Insight
Article

FAQ

Why Very Bearish?

The stock's significant drop post-earnings signals severe market concerns about SRTS's financial performance and potential fraud.

How important is it?

The investigation and poor financial results create high uncertainty, profoundly affecting investor sentiment and stock valuation.

Why Short Term?

Immediate reactions to earnings results and ongoing investigations will likely continue to affect SRTS's stock price.

Related Companies

SRTSNASDAQPOMSecurities Fraud
, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ: SRTS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Sensus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On August 7, 2025, Sensus reported its financial results for the second quarter of 2025, revealing a second quarter GAAP earnings-per-share figure of -$0.06, missing estimates by $0.09, and revenue of $7.3M, representing a -20.7% year-over-year decline and missing estimates by $2M.  Sensus attributed the decrease in revenue primarily to a lower number of units sold to a large customer, partially offset by growth in recurring revenue from Fair Deal Agreements.  On this news, Sensus's stock price fell $1.89 per share, or 35.32%, to close at $3.46 per share on August 8, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. Attorney advertising. Prior results do not guarantee similar outcomes.   CONTACT:Danielle PeytonPomerantz LLP[email protected]646-581-9980 ext. 7980 SOURCE Pomerantz LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News